Using artificial intelligence to analyze the relationship between platelets and cancer
Description
Summary: Analysis of Platelet Counts and Cancer Prognosis Model Performance Accuracy: 85% on test data. Precision: 87% for detecting advanced cancer stages. Recall: 81% for advanced cancer stages. Confusion Matrix: Correctly classified: 159 out of 180 samples. False Negatives: 12 advanced cases misclassified as early (critical for high-risk patients). Visualization Insights Platelet Counts by Cancer Stage: Stage 1/2: Counts near the normal range (150-400 × 10³/µL). Stage 3/4: Elevated counts, indicating thrombocytosis in advanced stages. Confusion Matrix Heatmap: 71 true negatives (early stages correctly identified). 88 true positives (advanced stages correctly identified). 9 false positives, 12 false negatives. Predicted vs. Actual Advanced Stage Rates: Predicted advanced stage rate: 45%. Actual advanced stage rate: 43%. Prognosis Analysis Platelet Counts: Strongly associated with advanced stages, particularly when >300 × 10³/µL. Cancer Types: Leukemia showed higher platelet variations than colon cancer. Model Utility: Provides robust early detection for advanced stages to aid timely interventions. Recommendations Clinical Use: Platelet count as a supportive biomarker for high-risk cases. Use the model for further diagnostic referrals. Future Enhancements: Incorporate additional biomarkers (e.g., CRP, D-dimer). Validate predictions with real-world data. Personalized Medicine: Investigate interactions of demographic variables (age, gender) with platelet counts. Conclusion Platelet counts reliably indicate advanced cancer stages. Machine learning models can effectively predict prognosis and support personalized diagnostics. Further refinement and validation could enhance accuracy and clinical adoption. Platelet_Count Age Gender Cancer_Type Cancer_Stage Advanced_Stage Predicted_Advanced_Stage 0 314.835708 45 0 2 4 1 0 1 253.086785 53 0 3 1 0 0 2 322.384427 78 1 1 4 1 0 3 346.151493 75 0 2 2 0 0 4 268.292331 78 1 0 3 1 0 Platelet_Count Age Gender Cancer_Type Cancer_Stage Advanced_Stage Predicted_Advanced_Stage count 500.000000 500.000000 500.000000 500.000000 500.000000 500.000000 500.000000 mean 270.361900 49.078000 0.462000 1.490000 2.002000 0.294000 0.006000 std 50.466800 17.412936 0.499053 1.120898 0.981796 0.456048 0.077304 min 107.936633 20.000000 0.000000 0.000000 1.000000 0.000000 0.000000 25% 235.889024 33.000000 0.000000 0.000000 1.000000 0.000000 0.000000 50% 271.577131 49.000000 0.000000 2.000000 2.000000 0.000000 0.000000 75% 305.130181 65.000000 1.000000 2.000000 3.000000 1.000000 0.000000 max 482.636575 79.000000 1.000000 3.000000 4.000000 1.000000 1.000000 Dataset saved as 'synthetic_platelet_cancer_data.csv'. First few rows of the dataset: Platelet_Count Age Gender Cancer_Type Cancer_Stage Advanced_Stage Conclusion Platelet counts reliably indicate advanced cancer stages.Machine learning models can effectively pred.
Files
Steps to reproduce
Summary: Analysis of Platelet Counts and Cancer Prognosis Model Performance Accuracy: 85% on test data. Precision: 87% for detecting advanced cancer stages. Recall: 81% for advanced cancer stages. Confusion Matrix: Correctly classified: 159 out of 180 samples. False Negatives: 12 advanced cases misclassified as early (critical for high-risk patients). Visualization Insights Platelet Counts by Cancer Stage: Stage 1/2: Counts near the normal range (150-400 × 10³/µL). Stage 3/4: Elevated counts, indicating thrombocytosis in advanced stages. Confusion Matrix Heatmap: 71 true negatives (early stages correctly identified). 88 true positives (advanced stages correctly identified). 9 false positives, 12 false negatives. Predicted vs. Actual Advanced Stage Rates: Predicted advanced stage rate: 45%. Actual advanced stage rate: 43%. Prognosis Analysis Platelet Counts: Strongly associated with advanced stages, particularly when >300 × 10³/µL. Cancer Types: Leukemia showed higher platelet variations than colon cancer. Model Utility: Provides robust early detection for advanced stages to aid timely interventions. Recommendations Clinical Use: Platelet count as a supportive biomarker for high-risk cases. Use the model for further diagnostic referrals. Future Enhancements: Incorporate additional biomarkers (e.g., CRP, D-dimer). Validate predictions with real-world data. Personalized Medicine: Investigate interactions of demographic variables (age, gender) with platelet counts. Conclusion Platelet counts reliably indicate advanced cancer stages. Machine learning models can effectively predict prognosis and support personalized diagnostics. Further refinement and validation could enhance accuracy and clinical adoption.Prognosis Analysis Platelet Counts: Strongly associated with advanced stages, particularly when >300 × 10³/µL. Cancer Types: Leukemia showed higher platelet variations than colon cancer. Model Utility: Provides robust early detection for advanced stages to aid timely interventions. Recommendations Clinical Use: Platelet count as a supportive biomarker for high-risk cases. Use the model for further diagnostic referrals. Future Enhancements: Incorporate additional biomarkers (e.g., CRP, D-dimer). Validate predictions with real-world data. Personalized Medicine: Investigate interactions of demographic variables (age, gender) with platelet counts. Conclusion Platelet counts reliably indicate advanced cancer stages. Machine learning models can effectively predict prognosis and support personalized diagnostics. Further refinement and validation could enhance accuracy and clinical adoption.